Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

197
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

221
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal manometry in an infant.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Endoscopic Stenting for the Treatment of Boerhaave's Syndrome.

The American surgeon·2025
Same author

Correlation of serum vitamin D levels with serum interleukin-23 levels in patients of ulcerative colitis.

Human immunology·2025
Same author

Primary Duodenal Aspergillosis in Poorly Controlled Diabetes: A Rare Entity.

The Journal of the Association of Physicians of India·2024
Same author

Cameron lesion with severe iron deficiency anemia and review of literature.

Caspian journal of internal medicine·2022
Same author

Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India.

Current vascular pharmacology·2021

Related Experiment Video

Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

MASLD-A Gateway for ASCVD: A Call for Early Intervention and Multidisciplinary Care.

Prabhash Chand Manoria1, Piyush Manoria2

  • 1Director, Department of Cardiology, Manoria Heart and Critical Care Hospital, Bhopal, Madhya Pradesh, India, Orcid: https://orcid.org/0009-0003-0620-6157, Corresponding Author.

The Journal of the Association of Physicians of India
|December 14, 2025
PubMed
Summary

Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases cardiovascular disease risk, becoming the leading cause of mortality in affected individuals. Early recognition and management of MASLD are crucial for preventing severe cardiovascular outcomes.

More Related Videos

Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties
12:55

Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties

Published on: September 27, 2020

8.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties
12:55

Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties

Published on: September 27, 2020

8.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Area of Science:

  • Hepatology
  • Cardiology
  • Public Health

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD), previously NAFLD, affects 25% globally, with rising prevalence.
  • Traditionally viewed as liver-specific, MASLD is now recognized as a multisystem disease impacting overall health.
  • Cardiovascular disease (CVD) is the primary cause of mortality in MASLD patients, exceeding liver-related issues.

Purpose of the Study:

  • To highlight the significant link between MASLD and increased cardiovascular morbidity and mortality.
  • To underscore MASLD's role as a critical risk factor for atherosclerotic cardiovascular disease (ASCVD).
  • To emphasize the systemic implications of MASLD beyond hepatic manifestations.

Main Methods:

  • Review of current epidemiological data and clinical evidence linking MASLD to cardiovascular outcomes.
  • Analysis of prevalence data for MASLD in relation to cardiovascular risk factors like type 2 diabetes mellitus (T2DM).
  • Synthesis of research on the mechanisms underlying the association between MASLD and various cardiovascular diseases.

Main Results:

  • MASLD prevalence has increased from 22% in 1991 to 37% in 2019.
  • Up to 75% of patients with type 2 diabetes mellitus (T2DM) also have MASLD.
  • MASLD is associated with higher risks of arrhythmia, atherosclerotic heart disease, heart failure, and CVD mortality.

Conclusions:

  • MASLD is a multisystem disease with profound cardiovascular implications.
  • ASCVD is the leading cause of death in MASLD patients.
  • MASLD represents a critical gateway for cardiovascular morbidity and mortality, necessitating integrated management strategies.